![](\"https:\/\/www.thestreet.com\/.image\/c_fit%2Ch_800%2Cw_1200\/NDA6MDAwMDAwMDAyOTMyNjc0\/alex-karp-chief-executive-officer-of-palantir-technologies-inc-walks-to-lunch-during-the-allen-co-media-and-technology-conference-in-sun-valley-idaho-us-on-thursday-july-10-2025-the-annual-event-has-b.jpg\")
<\/p>\n<\/p>\n
Palantir Technologies(PLTR) is one of the darlings of the stock market these days, with a one-year return of more than 90%. <\/p>\n
As the world reels from conflict on multiple fronts, Palantir is perhaps the most sought-after and researched stock in the world. But a new BBC interview is landing just as the company faces fresh pressure in the U.K. over its National Health Service (NHS) contract, its defense work, and wider controversy tied to Israel, surveillance, and the Pentagon.<\/p>\n
There are now two narratives shaping the discourse surrounding Palantir. One concerns the stock as a defensive move in a highly charged wartime atmosphere. The other is that the stock could become a potential liability, considering Palantir’s intimate ties to the security establishment.<\/p>\n
It’s in the current backdrop, where Palantir Technologies U.K. Executive Vice President Louis Mosley defended the company\u2019s military AI work in the BBC interview. His argument is simple and straightforward: Palantir builds tools designed to accelerate decision-making, not replace human judgment.<\/p>\n
The company’s military customers are “the ones that decide the policy framework that determines who gets to make what decision,” Mosley said. “That’s not [Palantir’s] role.” This stance clearly shifts the blame for any fallout regarding decisions.<\/p>\n
Incidentally, the defense comes at a critical time for Palantir, as it faces substantial questions from Britain regarding its future in that country. Palantir is already facing the music over its \u00a3330 million NHS Federated Data Platform contract, and lawmakers have also challenged a separate 12-week contract the company won from Britain\u2019s Financial Conduct Authority.<\/p>\n
The result is that the BBC interview no longer reads like just a defense story. It now feeds directly into a broader U.K. debate over whether Palantir should retain access to sensitive information concerning the U.K. public.<\/p>\n
For investors, it becomes a real headline risk issue. Palantir\u2019s ties to governments are a major reason the stock is worth so much. But the same contracts that support growth are also creating more political, ethical, and reputational risk. That creates a unique problem for PLTR stockholders.<\/p>\n
On the one hand, you want to buy the stock because it’s got great sticky revenue. On the other hand, things are getting worse, thanks to those very contracts.<\/p>\n
Palantir\u2019s U.K. problems are getting harder to ignore<\/p>\n
The biggest news from Palantir in recent months happens to be from the NHS deal. Reports say British ministers have looked into whether they can use a break clause to end Palantir’s seven-year, \u00a3330 million contract.<\/p>\n
Critics who don’t like the idea have raised issues including trust, openness, vendor lock-in, and whether a company that’s so closely linked to defense and immigration enforcement should be in the business of British health care.<\/p>\n
The problem for these critics is that the contract is already live at scale. NHS England says that by the end of February 2026, 123 trusts were live on the Federated Data Platform, 80 trusts were reporting benefits, 168 trusts had signed up, and 41 integrated care boards were active.<\/p>\n
Supporters say the system is firing on all cylinders. Palantir touts an increase of 110,000 surgeries, a 12% decrease in discharge delays, and removal of more than 675,000 patients from the waiting list, revealed a Medact briefing. <\/p>\n
But those claims, based on data that are not publicly available, haven’t stopped the backlash.<\/p>\n
The second U.K. controversy is small but equally telling. Britain\u2019s FCA defended its decision to give Palantir a short contract tied to financial-crime work, saying Palantir would act only as a data processor and would not get any overtly sensitive intelligence. <\/p>\n
Even so, MPs used the hearing to question whether Palantir now holds too much data on the U.K. populace.<\/p>\n
Why Palantir is drawing fresh heat in the U.K.The NHS contract is big and comes with political repercussions. There is a lot of data on the line.The platform is already live at scale. That makes it tough to unwind the contract.The backlash is spreading. MPs, campaigners, and some doctors are all complaining.The BBC interview added fuel. It tied Palantir\u2019s U.K. public-sector push more closely to its military AI identity.<\/p>\n
Palantir’s U.K. boss defends military AI as U.K. backlash grows.<\/p>\n
Photo by Kevin Dietsch on Getty Images<\/p>\n
Palantir\u2019s Pentagon gains are also driving controversy<\/p>\n
The U.K. controversy is only a tiny sliver of what is happening. In the U.S., the Pentagon will make Palantir\u2019s Maven system an official military program of record, Reuters reported March 20. That would guarantee long-term funding and enlarge Maven’s role in the military. That’s a big win for Palantir’s business.<\/p>\n
But like it or not, it raises the stakes as well. Reuters reported that Maven analyzes data to help lock certain targets on the battlefield. During said war exercises, Palantir says human oversight remains in place.<\/p>\n
More AI Stocks:<\/p>\n
Morgan Stanley drops eye-popping Broadcom price targetMorgan Stanley sets jaw-dropping Micron price target after eventBank of America updates Palantir stock forecast after private meeting<\/p>\n
Even so, experts have warned about the legal and ethical risks of increasingly automated military systems that rely on data rather than pure human willpower.<\/p>\n
There is also a newer operational wrinkle. Palantir may need months to remove Anthropic\u2019s Claude from parts of Maven after the Pentagon soured on Claude, terming it a supply-chain risk, Reuters reported in March. <\/p>\n
That shows how important and complicated Maven has become.<\/p>\n
Israel, Gaza, surveillance, and investors are all part of the Palantir story now<\/p>\n
Palantir\u2019s ties to Israel make it difficult to restrain the story. In its 2024 annual report, the company said it agreed to a partnership with the Israeli Defense Ministry to supply technology to assist in an increasingly unpopular war that has dragged on for years at this point.<\/p>\n
Palantir has denied providing the technology behind the Israeli systems known as Gospel or Lavender.<\/p>\n
That does not prove Palantir software is in use for a particular strike in Gaza, but it does make the company think about a bigger question it can’t seem to shake. Can a business that helps militaries find, sort, and act on battlefield data really dodge the effects of faster, more automated war?<\/p>\n
That question is already delving into investor behavior. In October 2024, Reuters reported that Norway\u2019s Storebrand Asset Management offloaded its Palantir stake over concerns tied to the company\u2019s work for Israel and the risk of violating international law.<\/p>\n
Palantir is also still taking heat over its immigration enforcement work with ICE, according to Reuters. In February 2026, Reuters reported that CEO Alex Karp argued in favor of the data analytics company’s defense work, saying government contracts helped drive sales.<\/p>\n
U.S. government revenue rose 66% to $570 million in the quarter, helping total revenue reach $1.41 billion.<\/p>\n
That is why the interview with the BBC is more important than it seems. Palantir claims governments can choose how to use its tools. <\/p>\n
Critics, however, say that software companies still decide what data is most important, how quickly decisions are made, and how much faith officials have in algorithmic systems.<\/p>\n
Why this matters for Palantir investors<\/p>\n
The bullish case is plain for all to see. Governments are putting more money into data systems, AI, defense, and fraud detection. Palantir keeps getting work in those areas, and its revenue clearly shows that it is gaining momentum.<\/p>\n
But the bear case for Palantir among all of these sectors is obvious as well. Investors may start to see Palantir’s stock differently if it becomes known not just as a fast-growing AI company but one linked to wars, surveillance, and sensitive public-sector systems.<\/p>\n
What investors should watch nextWhether U.K. ministers publicly take aim at the NHS deal: A real break-clause effort could turn this into a really nasty fight.How much deeper Maven goes inside the Pentagon: The more central it gets, the more attention and scrutiny it gets.Whether surveillance backlash grows: ICE- and government-related criticism is not going away and will only get worse from here.Whether institutional investors keep stepping back: Is Storebrand a warning sign, or a harbinger of things to come?How Palantir manages all of these issues: Its “We build the tool, governments decide” defense is now being put to the test in numerous places at once.<\/p>\n
Related: Palantir CEO makes blunt AI claim and investors should care<\/p>\n
#Lawmakers #send #stern #warning #Palantir<\/p>\n","protected":false},"excerpt":{"rendered":"
Palantir Technologies(PLTR) is one of the darlings of the stock market these days, with a…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[259],"tags":[2564,1893,3014,7263,856],"_links":{"self":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/3199"}],"collection":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3199"}],"version-history":[{"count":0,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/3199\/revisions"}],"wp:attachment":[{"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}